ATE509947T1 - Nukleinsäure involviert im responder phenotyp und deren verwendung - Google Patents

Nukleinsäure involviert im responder phenotyp und deren verwendung

Info

Publication number
ATE509947T1
ATE509947T1 AT98961219T AT98961219T ATE509947T1 AT E509947 T1 ATE509947 T1 AT E509947T1 AT 98961219 T AT98961219 T AT 98961219T AT 98961219 T AT98961219 T AT 98961219T AT E509947 T1 ATE509947 T1 AT E509947T1
Authority
AT
Austria
Prior art keywords
nucleic acid
present
acid molecules
relates
recombinant dna
Prior art date
Application number
AT98961219T
Other languages
English (en)
Inventor
Bernhard Herrmann
Birgit Koschorz
Andreas Kispert
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of ATE509947T1 publication Critical patent/ATE509947T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Structures Or Materials For Encapsulating Or Coating Semiconductor Devices Or Solid State Devices (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
AT98961219T 1997-11-18 1998-11-18 Nukleinsäure involviert im responder phenotyp und deren verwendung ATE509947T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97120190 1997-11-18
EP98103596 1998-03-02
PCT/EP1998/007395 WO1999025815A2 (en) 1997-11-18 1998-11-18 Nucleic acids involved in the responder phenotype and applications thereof

Publications (1)

Publication Number Publication Date
ATE509947T1 true ATE509947T1 (de) 2011-06-15

Family

ID=26145903

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98961219T ATE509947T1 (de) 1997-11-18 1998-11-18 Nukleinsäure involviert im responder phenotyp und deren verwendung

Country Status (7)

Country Link
US (2) US6642369B1 (de)
EP (1) EP1032595B1 (de)
JP (1) JP4749541B2 (de)
AT (1) ATE509947T1 (de)
AU (1) AU1671199A (de)
CA (1) CA2311166C (de)
WO (1) WO1999025815A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9926161D0 (en) * 1999-11-04 2000-01-12 Pig Improvement Company Uk Lim Methods
CN1291010C (zh) * 2000-02-24 2006-12-20 马萨诸塞大学 只生育单一性别后代的哺乳动物的生产
EP1476573B1 (de) 2002-01-28 2010-01-06 Ambion, Inc. Für den nachweis von nukleinsäuren kompetente biologische rohderivate
EP1752040A1 (de) * 2005-08-12 2007-02-14 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Isolierung eines t-Complex Distorters und dessen Verwendung
WO2026057190A1 (en) * 2024-09-11 2026-03-19 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Optimized nucleic acid molecule encoding a t-responder causing high sex ratio distortion

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
MC2115A1 (fr) 1987-12-15 1991-07-05 Gene Shears Pty Ltd Ribozynes
CA1340323C (en) 1988-09-20 1999-01-19 Arnold E. Hampel Rna catalyst for cleaving specific rna sequences
JPH07502886A (ja) * 1991-10-04 1995-03-30 ザ トラスティーズ オブ プリンストン ユニバーシティー 精子表面タンパク質

Also Published As

Publication number Publication date
JP2001523449A (ja) 2001-11-27
US20040010814A1 (en) 2004-01-15
WO1999025815A2 (en) 1999-05-27
EP1032595B1 (de) 2011-05-18
CA2311166C (en) 2012-06-19
EP1032595A2 (de) 2000-09-06
CA2311166A1 (en) 1999-05-27
WO1999025815A3 (en) 1999-08-19
US6642369B1 (en) 2003-11-04
JP4749541B2 (ja) 2011-08-17
AU1671199A (en) 1999-06-07

Similar Documents

Publication Publication Date Title
ATE198767T1 (de) Hantelförmige expressionskonstrukte für die gentherapie
ATE318900T1 (de) Ef-1-alpha transkriptionsregulatorische dna aus hamster
WO2002000894A3 (en) Gene silencing vector
YU65194A (sh) Promotorni elementi himernih gena za alfa-tubulin
DE60228212D1 (de) Neue expressionsvektoren
FI923444A0 (fi) Imidazolinonresistenta ahas-mutanter.
DK1017803T3 (da) Ekspression af endogene gener ved ikke-homolog rekombination af et vektorkonstrukt med cellulært DNA
ATE490321T1 (de) Induzierbare sirna expressionskonstrukte zur gezielten genabschaltung
PT98419A (pt) Processo para a preparacao de sequencias de adn que codificam para xilanases, de construcoes de adn que contem essas sequencias, paraa transformacao de hospedeiros microbianos com essas construcoes, para a preparacao de xilanases por expressao nesses hospedeiros e para a degradacao de xilano por accao dessas xilanases
DE602004031041D1 (de) In pflanzenplastiden funktionsfähiger promotor
CY1109579T1 (el) Μιμητοσωματα του πυρηνα αρθρωσης μιμητικα της ανθρωπινης ερο, συνθεσεις, μεθοδοι και χρησεις
DE60237542D1 (de) Ein system zur stabilen expression von sirnas in säugetierzellen
DE69738804D1 (de) Blütenorgan-spezifische promotersequenzen
ATE502043T1 (de) Hochempfindliche polymerasen und ihre verwendungen
ATE171212T1 (de) Corticotropin freisetzende rezeptoren des faktor 2
WO2000075279A3 (en) Nucleotide sequences for gene regulation and methods of use thereof
ATE509947T1 (de) Nukleinsäure involviert im responder phenotyp und deren verwendung
DE60130465D1 (de) Mutierte muskelspezifische enhancer
Rotková et al. An evolutionary change in telomere sequence motif within the plant section Asparagales had significance for telomere nucleoprotein complexes
Mondal et al. Advances in animal genomics
ATE349541T1 (de) Gen-expressionskonstrukt von hap1 modifiziert für planzenzellen
WO2005010142A8 (en) Plant centromere compositions
MXPA01004353A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
ATE406446T1 (de) Vermehrungsproteine von pflanzen
WO2003054217A3 (en) Plant msh2 sequences and methods of use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties